Laura Accettola
Vice President, Hematology/Oncology Therapeutic Unit Head
PPD

Yanghuan Bao
Founder
PRECISION BRAIN SCIENCE

Dejan Brkic
Senior Director, Regulatory Development Solutions Lead, Regulatory Affairs
PPD

Cristina Chang
Chief Medical Officer
HARVEST INTEGRATED RESEARCH ORGANIZATION

Jianqing Chang
Vice President, Regulatory Policy
TIGERMED

Feng Chen
Professor of Statistics
NANJING MEDICAL UNIVERSITY

Helen Chen
Global Sector Co-Head, Healthcare and Life Sciences & Greater China Managing Partner
L.E.K. CONSULTING

PJ Chen
Co-Founder & Chief Executive Officer
CALI BIOSCIENCES

Feng Cheng
Vice President of Business Development, APAC
VIEDOC TECHNOLOGIES

David Dai
Associate Director, Project Delivery
PPD

Ming Ding
Senior Vice President and General Manager, China Operations
PPD

Jinhui Dou
Vice President, Regulatory Affairs
ZHIMENG BIOPHARMA

Lan Feng
Secretary-General
PhIRDA

Jieying Fu
Regulatory Affairs Head
I-MAB BIOPHARMA

Qi Gao
Head of Oncology and Cell Therapy Clinical Operations, Asia
TAKEDA

Yan Gao
Founder & Chief Executive Officer
WM THERAPEUTICS

John Ge
Vice President, Clinical Operations
ALPHA BIOPHARMA

Tong Guo
Vice President, Head of Sales, Greater China
IQVIA RDS

Hettie Han
Chief Business Officer, General Manager for U.S. Commercial Operations
HEPALINK

Kun He
Chief Statistician & US Chief Executive Officer / Former Associate Division Director of Biometrics V, Officer of Biostatistics & CDER
R&G / US FDA

Denny Hou
Vice President, Medical Research
EVIVE BIOTECH

Ye Hua
Chairman & Chief Executive Officer
BIONOVA PHARMACEUTICALS

Frank Jiang
Chief Strategy Officer
HENGRUI PHARMA

Helen Jiang
Chief Medical Officer
ZHEJIANG YST CO.LTD

Paul Kong
Vice President of Clinical Operations
LANOVA MEDICINES

Chang Lee
Co-founder & Chief Medical Officer / Former medical reviewer
EVERGREEN THERAPEUTICS / US FDA

Jiang Li
Director, Real-World Evidence at Evidera
PPD

Qiang Li
Regional Epidemiology Lead Asia
BOEHRINGER INGELHEIM

Xiao Li
Head of Clinical Pharmacology, Global R&D
LUYE PHARMA

Xin Li
Senior Vice President, Head of Global Product Development China
ROCHE

Zili Li
DIA Fellow, Former VP and Head of Asia Pacific R&D
JANSSEN

Kevin Lin
Founder and CEO / Founder and Chairman
XINCERE MED TECH / JSURE HEALTH

Stephen Lin
Partner
LAV

Andy Liu
General Manager
NOVOTECH

Yanfei Liu
Director, Clinical Trials Institute / Inspector, Clinical Data, CFDI
FUDAN UNIVERSITY SHANGHAI CANCER CENTER / NMPA

Yi Liu
GM, Clinical Medicine Research Center
JEMINCARE

Zeyuan Liu
Former Director, Clinical Research Institutions
FIFTH MEDICAL CENTER OF PLA GENERAL HOSPITAL

Jim Lu
Co-Founder & Chief Scientific Officer / Former reviewer of Center for Biologics Evaluation and Research
TRIARM THERAPEUTICS / US FDA

Yi Luo
Head, Hematopathy Therapeutical Area
ROCHE

Donglei Mao
Editor in Chief
PHARMADJ

Philippe Muller
Comparator Sourcing General Manager
PATHEON

Barry Murphy
Chief Commercial Officer
NOVOTECH

David Ng
Global Vice President, Biometrics and Data Management
NOVOTECH

Judith Ng-Cashin
Chief Medical Officer
NOVOTECH

Bin Peng
Part-time Chief Medical Officer
ENNOVABIO

Jian Peng
Executive Vice President, Drug Development and Regulatory Strategy
ZELGEN BIOPHARMACEUTICALS

Dirk Reitsma
Senior Vice President, Global Product Development, Therapeutic Area Head Oncology
PPD

Rainbow Ruan
Country Head Portfolio of Study and Site Operations
NOVARTIS DEVELOPMENT CHINA

Yi Shao
Partner
MCKINSEY & COMPANY

Joan Shen
Founder & Chief Executive Officer
NEUSHEN THERAPEUTICS

Michael Shi
Executive Vice President, Head of R&D and Chief Medical Officer
HUTCHMED

Qingmei Shi
Senior Vice President, Clinical Development
CSTONE PHARMACEUTICALS

Yuqin Song
Vice President & Deputy Director, Lymphoma Department
PEKING UNIVERSITY CANCER HOSPITAL

Michael Stibilj
Chief Operating Officer
NOVOTECH

Xiaodi Su
Principal
LAV

Xing Sun
Vice President, Biostatistics And Information Science
INNOVENT BIOLOGICS

Zhigang Sun
Senior Vice President, Global R&D / Former acting branch chief at Office of Process and Facilities, the CMC team leader at Office of Generic Drugs,the U.S.FDA, and the Acting Assistant Country Director for Drugs
LUYE PHARMA / US FDA China Office

Tetsuomi Takano
Editor in Chief
DRUG R&D EXPERT

Dean Tang
Senior Director, Sales Operations & Corporate Strategy
NOVOTECH

Gary Wang
Vice President, Clinical Development
LAEKNA THERAPEUTICS

Lin Wang
Vice President of Research and Development, Head of TDC Asia
TAKEDA

Yu Wang
Chief Medical Officer
GenFleet Therapeutics

Kim Watanabe
Executive Director, Cell and Gene Therapy Pillar Head
PPD

Cuicui Wu
Deputy Director of Pharmacovigilance
TIPV TIGERMED

Ting Wu
Senior Director, Dept. of China Value, Evidence, and Outcomes, LCDDMAC
ELI LILLY

Yingjie Wu
Executive Director, Search and Evaluation Oncology R&D, Business Development
ASTRAZENECA

Leon Wyszkowski
President, Head of Laboratory Service
PPD

Anbo Xiang
President, Clinical business unite & Chief Medical Officer, Non-oncology
CSPC

Yan Xiao
Senior Director, Rare Disease Group, Digital and Data Innovation
ASTRAZENECA

David Xie
Partner, China Life Sciences & Health Care
Deloitte Consulting

Tao Xu
Medical Director
PPD

Bin Xue
Executive Director / Former Director-General
CHINA SOCIETY FOR DRUG REGULATION / NMPA CHINA CENTER FOR FOOD AND DRUG INTERNATIONAL EXCHANGE(CCFDIE)

Fangrong Yan
Head of the Department of Biostatistics, Director of the Research Center for Biostatistics and Computational Pharmacy
CHINA PHARMACEUTICAL UNIVERSITY

Jason Yang
Chief Executive Officer
CSTONE PHARMA

Yongsheng Yang
Senior Vice President, Director of Nucleic Acid Medicine Innovation Center / Former pharmacologist
HAICHANG BIOTECH / US FDA

Chen Yao
Director, Medical Statistics
PEKING UNIVERSITY FIRST HOSPITAL

He Ye
Fourth Consultant, Multilateral Cooperation Division，Department of Science, Technology and Global Cooperation (Hong Kong, Macao and Taiwan Office)
NMPA

Weihong Yuan
Director of Real-world Studies
HAINAN LECHENG REAL-WORLD RESEARCH INSTITUTE

Amily Zhang
Chief Medical Officer
ANTENGENE

Hefei Zhang
Senior Medical Director, Early Phase Clinical Research
MSD CHINA

Jian Zhang
Executive Director, Phase I Clinical Research
FUDAN UNIVERSITY SHANGHAI CANCER CENTER

Lianshan Zhang
President of R&D
HENGRUI MEDICINE

Nan Zhang
General Manager, Clinical Trials Division, China
PATHEON

Yu Zhang
Vice President, Global R&D China Center, Head Of Product Pipeline And Project Management
ASTRAZENECA

Jason Zhou
Chief Medical Officer
BOAN BIOTECH

Richard Zhou
Chief Financial Officer & Secretary of the Board
KELUN BIOTECH

Xianbo Zhou
Founder & Chief Executive Officer
ASTRANEURA

Jason Zhu
Chief Executive Officer, President & Chief Financial Officer
HENLIUS

John Zhu
Founder & Chief Executive Officer
DUALITY BIOLOGICS

Yonghong Zhu
Chief Medical Officer
EPIMAB BIOTHERAPEUTICS

Meriam Djemai Zoghlache
ED, Early Development Pillar Head HemOnc
PPD

Jun Zuo
Executive Vice President, Regulatory Affairs
TENACIA BIOTECHNOLOGY